• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

1,2,3-Benzenetriol,5-(2-aminoethyl)-, Hydrochloride (1:1) (CAS No. 5720-26-3): An In-Depth Overview

1,2,3-Benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) (CAS No. 5720-26-3) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 5-(2-aminoethyl)catechol hydrochloride, is a derivative of catechol and has garnered attention due to its unique chemical structure and potential biological activities.

The chemical structure of 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) consists of a catechol moiety with an aminoethyl group attached at the 5-position. The presence of the catechol group imparts antioxidant properties to the molecule, while the aminoethyl group provides additional reactivity and functional versatility. The hydrochloride salt form ensures solubility in aqueous media, making it suitable for various biological assays and pharmaceutical formulations.

Recent research studies have explored the potential therapeutic applications of 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1). One notable area of interest is its role as an antioxidant. Catechols are known for their ability to scavenge free radicals and protect cells from oxidative damage. This property makes 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) a promising candidate for the development of neuroprotective agents and treatments for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

Moreover, the aminoethyl group in 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) provides opportunities for further chemical modifications and conjugations. This functional group can be used to attach various biomolecules or drug moieties to create targeted drug delivery systems or prodrugs. For instance, conjugation with peptides or antibodies can enhance the specificity and efficacy of therapeutic interventions.

In addition to its antioxidant properties and potential as a drug delivery platform, 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) has been investigated for its anti-inflammatory effects. Inflammatory responses are central to many diseases, including cardiovascular diseases and autoimmune disorders. Studies have shown that this compound can modulate inflammatory pathways by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) could be developed into anti-inflammatory drugs with fewer side effects compared to traditional non-steroidal anti-inflammatory drugs (NSAIDs).

The pharmacokinetic properties of 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) have also been studied extensively. Research indicates that it has good bioavailability when administered orally or intravenously. The compound is rapidly absorbed into the bloodstream and distributed to various tissues. However, it is important to note that the half-life of 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) is relatively short due to its metabolic degradation by enzymes such as catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). This rapid metabolism necessitates careful dosing regimens to maintain therapeutic levels in the body.

Toxicity studies on 1,2,3-benzenetriol,5-(2-aminoethyl)-, hydrochloride (1:1) have shown that it is generally well-tolerated at therapeutic doses. However, high concentrations can cause adverse effects such as gastrointestinal irritation and hepatotoxicity. Therefore, it is crucial to conduct thorough safety evaluations before advancing this compound into clinical trials.

In conclusion, 1，2，3-benzenetriol，5-(2-aminoethyl)-，hydrochloride (1:1) (CAS No. 5720-26-3) is a multifaceted compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure endows it with antioxidant properties and functional versatility for drug delivery systems. Ongoing research continues to uncover new therapeutic possibilities for this compound in areas such as neuroprotection and anti-inflammation. As our understanding of its biological activities deepens, 1，2，3-benzenetriol，5-(2-aminoethyl)-，hydrochloride (1:1) may become an important tool in the development of novel drugs and treatments for various diseases.

• 51-61-6(Dopamine)
• 588-05-6(m-Tyramine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)